Efficacy of silodosin in benign prostatic hyperplasia with overactive bladder.
Not Applicable
Recruiting
- Conditions
- Benign prostatic hyperplasia
- Registration Number
- JPRN-UMIN000007917
- Lead Sponsor
- Study group of voiding dysfunction in North part of Kyushu area
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have a structural disease (e.g. prostatic cancer, bladder neck contracture, urethral stricture). 2) Patients with genitourinary surgery (e.g. TURP) or non-invasive treatment (e.g. balloon dilation, urethral stent, thermotherapy) within previous 6 months. 3) Patients with indwelling urethral cathether or clean-intermittent catheterization. 4) Patients with active urinary tract infections 5) Patients with neurogenic lower urinary tract disorders. 6) Patients having a history of allergic reaction caused by silodosin. 7) Patients who judged as being inadequate for this trial by the researcher.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method International Prostate Symptom Score (IPSS)
- Secondary Outcome Measures
Name Time Method Overactive bladder symptom score (OABSS)Uroflowmetry Residual urine volume